User:Mr. Ibrahem/Theophylline
Clinical data | |
---|---|
Trade names | Theolair, Slo-Bid, others |
Other names | 1,3-dimethylxanthine |
AHFS/Drugs.com | Monograph |
MedlinePlus | a681006 |
Pregnancy category |
|
Routes of administration | By mouth, IV[2] |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 100% (IV) |
Protein binding | 40% (primarily to albumin) |
Metabolism | Liver to 1-methyluric acid |
Elimination half-life | 5–8 hours |
Identifiers | |
| |
Chemical and physical data | |
Formula | C7H8N4O2 |
Molar mass | 180.167 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Theophylline, sold under various brand names, is a medication used for chronic obstructive pulmonary disease (COPD) and asthma.[2] Use has largely been replaced by other bronchodilators with greater safety.[3] It is used by mouth or by injection into a vein.[2] Theophylline blood levels require periodic monitoring.[4]
Common side effects include nausea, headache, trouble sleeping, abdominal pain, palpitations, and diarrhea.[2] Severe side effects may include low blood potassium.[4] Excessive doses can result in severe side effects.[4] The dose may need to be adjusted depending on if someone smokes, uses alcohol, or has liver or heart problems.[4] Use during pregnancy is of unclear safety.[1] It is in the xanthine family of medications.[2] How it works is not entirely clear.[2]
Theophylline was isolated in 1888 from the tea plant (Camellia sinensis).[3] It is available as a generic medication.[2] In the United Kingdom a month of medication costs the NHS about 5 pounds.[4]
References[edit]
- ^ a b "Theophylline Use During Pregnancy". Drugs.com. Archived from the original on 29 November 2020. Retrieved 9 October 2020.
- ^ a b c d e f g "Theophyllines Monograph for Professionals". Drugs.com. Archived from the original on 23 September 2020. Retrieved 9 October 2020.
- ^ a b Sneader, Walter (2005). Drug Discovery: A History. John Wiley & Sons. p. 95. ISBN 978-0-471-89979-2. Archived from the original on 2021-08-29. Retrieved 2020-10-09.
- ^ a b c d e BNF 79 : March 2020. London: Royal Pharmaceutical Society. 2020. p. 282. ISBN 9780857113658.